Fundraising FoxEgetis Therapeutics
1 known investors
Find your way into Egetis Therapeutics
Sign up to see every warm intro you have to Egetis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Egetis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Egetis Therapeutics is a pharmaceutical company developing treatments for rare and serious diseases, including Emcitate (tiratricol) for MCT8 deficiency. Its work centers on orphan drug development in the biotech and healthcare space.
Investors · 1
In the news
Frequently asked questions
- What does Egetis Therapeutics do?
- Egetis Therapeutics is a pharmaceutical company developing treatments for rare and serious diseases, including Emcitate (tiratricol) for MCT8 deficiency. Its work centers on orphan drug development in the biotech and healthcare space.
- Who are Egetis Therapeutics's investors?
- Egetis Therapeutics's investors include Kreos Capital.